NCT01179373

Deep Transcranial Magnetic Stimulation for Treatment of Alzheimer's Disease

Phase 2 Study of Trans Cranial Magnetic Stimulation as Additional Therapy Patients With Alzheimer's Disease

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 45 (estimated)
• Sponsor: Brainsway · Industry
• Sex: All
• Age: 50 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of this trial is to assess the ability of Transcranial Magnetic Stimulation with H coil to prefrontal cortex , with an addition of cognitive brain training, to improve cognitive performance in patients with Alzheimer's disease which received drug treatment. This study is a single-center, double-blind 4 months duration trial.

Detailed description

Primary outcome measure: ADAS-COG (time frame baseline, 2 months, 4 months) Secondary outcome measure: CGI-C,FAB, ADL, Neuropsychological computerized test(time frame baseline, 2 months, 4 months. Estimated enrollment: 40 patients Estimated Study start Date: November 2008 Estimated Study Completion date: November 2009 Number of arms: 2 Ages: 50-85 Genders: both

Conditions

• Alzheimer's Disease

Interventions

Type	Name	Description
DEVICE	TMS, H coil	TMS, H Coil, High/ Low Frequency

Timeline

• Start date: 2010-08-01
• Primary completion: 2015-01-01
• Completion: 2015-06-01
• First posted: 2010-08-11
• Last updated: 2018-01-25

Locations

1 site across 1 country: Israel